J
Jan Erik Nordrehaug
Researcher at University of Bergen
Publications - 222
Citations - 11036
Jan Erik Nordrehaug is an academic researcher from University of Bergen. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 41, co-authored 211 publications receiving 10163 citations. Previous affiliations of Jan Erik Nordrehaug include Guerbet & Deaconess Hospital.
Papers
More filters
Journal ArticleDOI
Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.
Sigmund Silber,Per Albertsson,Francisco Fernández Avilés,Paolo G. Camici,Antonio Colombo,Christian W. Hamm,Erik Jørgensen,Jean Marco,Jan Erik Nordrehaug,Witold Rużyłło,Philip Urban,Gregg W. Stone,William Wijns +12 more
TL;DR: Overall, the superiority of primary PCI over thrombolysis seems to be especially clinically relevant for the time interval between 3 and 12 h after onset of chest pain or other symptoms on the basis of its superior preservation of myocardium.
Journal ArticleDOI
Homocysteine lowering and cardiovascular events after acute myocardial infarction.
Kaare H. Bønaa,Inger Njølstad,Per Magne Ueland,Henrik Schirmer,Aage Tverdal,Terje K. Steigen,Harald Wang,Jan Erik Nordrehaug,Egil Arnesen,Knut Rasmussen +9 more
TL;DR: Treatment with B vitamins did not lower the risk of recurrent cardiovascular disease after acute myocardial infarction and a harmful effect from combined B vitamin treatment was suggested.
Journal ArticleDOI
Recommendations for competitive sports participation in athletes with cardiovascular disease : a consensus document from the study group of sports cardiology of the working group of cardiac rehabilitation and exercise physiology and the working group of myocardial and pericardial diseases of the european society of cardiology
Antonio Pelliccia,Robert Fagard,H H Björnstad,Aris Anastassakis,Eloisa Arbustini,Deodato Assanelli,Alessandro Biffi,Mats Börjesson,François Carré,Domenico Corrado,Pietro Delise,Uwe Dorwarth,Asle Hirth,Hein Heidbuchel,Ellen Hoffmann,Klaus Peter Mellwig,Nicole M. Panhuyzen-Goedkoop,Angela Pisani,Erik Ekker Solberg,Frank van-Buuren,Luc Vanhees,Carina Blomström-Lundqvist,Asterios Deligiannis,Dorian Dugmore,Michael Glikson,Per Ivar Hoff,Andreas Hoffmann,Erik Hoffmann,Dieter Horstkotte,Jan Erik Nordrehaug,Jan Oudhof,William J. McKenna,Maria Penco,Silvia G. Priori,Tony Reybrouck,Jeff Senden,Antonio Spataro,Gaetano Thiene +37 more
TL;DR: A consensus document from the Study Group of Sports Cardiology and the Working Group of Cardiac Rehabilitation and Exercise Physiology of the European Society of Cardiology has been published in this paper.
Journal ArticleDOI
Serum Total Homocysteine and Coronary Heart Disease
Egil Arnesen,Helga Refsum,Kaare H. Bønaa,Per Magne Ueland,Olav Helge Førde,Jan Erik Nordrehaug +5 more
TL;DR: In the general population serum total homocysteine is an independent risk factor for CHD with no threshold level, and there was no thresholdlevel above which serum homocy steine is associated with CHD events.
Journal ArticleDOI
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
Marta Ebbing,Øyvind Bleie,Per Magne Ueland,Jan Erik Nordrehaug,Dennis W.T. Nilsen,Stein Emil Vollset,Helga Refsum,Eva Ringdal Pedersen,Ottar Nygård +8 more
TL;DR: The findings do not support the use of B vitamins as secondary prevention in patients with coronary artery disease or aortic valve stenosis and mean plasma total homocysteine concentration was reduced by 30% after 1 year of treatment in the groups receiving folic acid and vitamin B(12).